Regiospecific synthesis of rapamycin 42-ester derivatives

Details for Australian Patent Application No. 2005238431 (hide)

Owner Wyeth

Inventors Gu, Jianxin; Cai, Ping; Ruppen, Mark E.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005238431

PCT Pub. Number WO2005/105811

Priority 60/561,926 14.04.04 US

Filing date 12 April 2005

Wipo publication date 10 November 2005

International Classifications

C07D 498/18 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

2 November 2006 PCT application entered the National Phase

  PCT publication WO2005/105811 Priority application(s): WO2005/105811

10 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005238432-Process for preparing rapamycin 42-esters and FK-506 32-esters with dicarboxylic acid, precursors for rapamycin conjugates and antibodies

2005238430-Wet scrubbing and recycle of effluentcontaminating catalyst particles in an oxygenate-to-olefin process